Fabrice Piu
ACADIA Pharmaceuticals Inc
San Diego
USA
Name/email consistency: high
- Broad modulation of neuropathic pain states by a selective estrogen receptor beta agonist. Piu, F., Cheevers, C., Hyldtoft, L., Gardell, L.R., Del Tredici, A.L., Andersen, C.B., Fairbairn, L.C., Lund, B.W., Gustafsson, M., Schiffer, H.H., Donello, J.E., Olsson, R., Gil, D.W., Brann, M.R. Eur. J. Pharmacol. (2008)
- Pharmacological characterization of AC-262536, a novel selective androgen receptor modulator. Piu, F., Gardell, L.R., Son, T., Schlienger, N., Lund, B.W., Schiffer, H.H., Vanover, K.E., Davis, R.E., Olsson, R., Bradley, S.R. J. Steroid Biochem. Mol. Biol. (2008)
- Beta-arrestin 2 modulates the activity of nuclear receptor RAR beta2 through activation of ERK2 kinase. Piu, F., Gauthier, N.K., Wang, F. Oncogene (2006)
- Identification of novel subtype selective RAR agonists. Piu, F., Gauthier, N.K., Olsson, R., Currier, E.A., Lund, B.W., Croston, G.E., Hacksell, U., Brann, M.R. Biochem. Pharmacol. (2005)
- Dissection of the cytoplasmic domains of cytokine receptors involved in STAT and Ras dependent proliferation. Piu, F., Magnani, M., Ader, M.E. Oncogene (2002)
- AP-1 repressor protein JDP-2: inhibition of UV-mediated apoptosis through p53 down-regulation. Piu, F., Aronheim, A., Katz, S., Karin, M. Mol. Cell. Biol. (2001)